Articles

Elsevier,

Pharmacological Research - Modern Chinese Medicine, Volume 12, September 2024

The study investigates the neuroprotective effects of hordenine against AlCl3-induced Alzheimer’s disease in rats. Results show that hordenine improves memory and cognitive functions, suggesting its potential to reverse oxidative stress and neuroinflammation associated with Alzheimer’s
Elsevier,

Brain Research, Volume 1838, 1 September 2024

The study demonstrates that the peptide PHDP5, which inhibits dynamin-MT interaction, can rescue impaired endocytosis and synaptic transmission caused by tau in presynaptic terminals. When administered intranasally to Alzheimer's disease (AD) model mice, PHDP5 significantly improved learning and memory, suggesting its potential as a candidate for human AD therapy.
Elsevier,

Carbon Capture Science and Technology, Volume 12, September 2024

This text ties into several Sustainable Development Goals (SDGs), particularly SDG 12 (Responsible Consumption and Production) and SDG 13 (Climate Action). It highlights the potential of lignin as a sustainable material that can reduce reliance on traditional plastics and contribute to carbon fixation, promoting circularity and environmental sustainability.
Elsevier,

Carbon Capture Science and Technology, Volume 12, September 2024

The article dives into various carbon capture technologies to provide a thorough understanding of the various techniques used in Carbon Capture, Utilization and Storage.
Elsevier,

Australian and New Zealand Journal of Public Health, Volume 48, August 2024

This paper seeks to describe and categorise some of the most common behaviours and practices of public health professionals and institutions that introduce or sustain systematic ethnic bias into public health work and thus potentially perpetuate or exacerbate Indigenous inequities in health.
Elsevier,

The American Journal of Medicine, Available online 27 August 2024

The present mini-commentary on Alzheimer's disease describes recently revealed pathogenic elements, evolving capabilities for identifying unusually high individual susceptibility and developing tests that predict onset preclinically to allow preventative approaches. Several potential therapies that target cellular signaling and other pathways that are abnormal in Alzheimer's disease are in early clinical trials and will be reviewed briefly.

Elsevier,

Progress in Neuro-Psychopharmacology and Biological Psychiatry, Volume 134, 30 August 2024

This study evaluated the behavioral, physiological, and molecular effects of social isolation (SI) in adult zebrafish, and whether the animals recover such changes after their reintroduction to the social environment. The results show that SI altered social behaviors, neural activity, and serotonergic and dopaminergic signaling in zebrafish, but these changes were reversed after the animals were reintroduced to a social context for 6 days.
RELX

More than 1100 people came together virtually on 18 June 2024 for the tenth edition of the RELX SDG Inspiration Day: "In the Age of AI: Information to Advance the UN Sustainable Development Goals (SDGs)." The annual online event brings together thought leaders, corporate representatives, students, investors, governments, and NGOs to explore pressing issues, gain practical insight, and inspire action on the United Nations Sustainable Development Goals (SDGs).

Elsevier,

Archives of Gerontology and Geriatrics Plus, Volume 1, Issue 4, December 2024, 100072

This study reveals that the estimation of lipids and carotenoid levels could support the early diagnosis or help to understand the pathophysiology of Alzheimer's Disease.

Pages